SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Structured Process to Identify Fit‐For‐Purpose Data: A Data Feasibility Assessment Framework
4 references·1 citing·16 second hop
The Structured Process to Identify Fit‐For‐Purpose Data: A Data Feasibility Assessment Framework (2021)The Structured Process to Identify Fit‐Fo…Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing—Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative (2020)Improving Transparency to Bui…The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE) (2018)The reporting of studies cond…Harnessing the Power of Real‐World Evidence (RWE): A Checklist to Ensure Regulatory‐Grade Data Quality (2017)Harnessing the Power of Real‐…European network for health technology assessment – EUnetHTA (2013)European network for health t…Use of Structured Template and Reporting Tool for Real-World Evidence for Critical Appraisal of the Quality of Reporting of Real-World Evidence Studies: A Systematic Review (2022)Use of Structured Template an…The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions (2016)Examining the Use of Real‐World Evidence in the Regulatory Process (2019)Measuring Medicine Use: Applying ATC/DDD Methodology to Real-World Data (2021)Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions (2022)Registration of observational studies: Is it time? (2010)Improving the Transparency of Prognosis Research: The Role of Reporting, Data Sharing, Registration, and Protocols (2014)Real-World Evidence for Regulatory Decision-Making: Guidance From Around the World (2022)The STROBE guidelines (2019)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)Accelerated Access to Innovative Medicines for Patients in Need (2014)Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries (2015)Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries (2021)Innovation at the Intersection of Clinical Trials and Real‐World Data Science to Advance Patient Care (2018)Use of Real‐World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design (2021)
this work references cited by second hop

References

  • 2018The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)632 cited
  • 2017Harnessing the Power of Real‐World Evidence (RWE): A Checklist to Ensure Regulatory‐Grade Data Quality192 cited
  • 2013European network for health technology assessment – EUnetHTA148 cited
  • 2020Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing—Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative126 cited

Cited by

  • 2022Use of Structured Template and Reporting Tool for Real-World Evidence for Critical Appraisal of the Quality of Reporting of Real-World Evidence Studies: A Systematic Review9 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work